136 related articles for article (PubMed ID: 21067438)
1. Bifunctional phenolic-choline conjugates as anti-oxidants and acetylcholinesterase inhibitors.
Sebestík J; Marques SM; Falé PL; Santos S; Arduíno DM; Cardoso SM; Oliveira CR; Serralheiro ML; Santos MA
J Enzyme Inhib Med Chem; 2011 Aug; 26(4):485-97. PubMed ID: 21067438
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, in vitro assay, and molecular modeling of new piperidine derivatives having dual inhibitory potency against acetylcholinesterase and Abeta1-42 aggregation for Alzheimer's disease therapeutics.
Kwon YE; Park JY; No KT; Shin JH; Lee SK; Eun JS; Yang JH; Shin TY; Kim DK; Chae BS; Leem JY; Kim KH
Bioorg Med Chem; 2007 Oct; 15(20):6596-607. PubMed ID: 17681794
[TBL] [Abstract][Full Text] [Related]
3. Benzophenone-based derivatives: a novel series of potent and selective dual inhibitors of acetylcholinesterase and acetylcholinesterase-induced beta-amyloid aggregation.
Belluti F; Bartolini M; Bottegoni G; Bisi A; Cavalli A; Andrisano V; Rampa A
Eur J Med Chem; 2011 May; 46(5):1682-93. PubMed ID: 21397996
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of 7,8-dehydrorutaecarpine derivatives as potential multifunctional agents for the treatment of Alzheimer's disease.
He Y; Yao PF; Chen SB; Huang ZH; Huang SL; Tan JH; Li D; Gu LQ; Huang ZS
Eur J Med Chem; 2013 May; 63():299-312. PubMed ID: 23501115
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and study of thiocarbonate derivatives of choline as potential inhibitors of acetylcholinesterase.
Boyle NA; Talesa V; Giovannini E; Rosi G; Norton SJ
J Med Chem; 1997 Sep; 40(19):3009-13. PubMed ID: 9301662
[TBL] [Abstract][Full Text] [Related]
6. Syntheses and characterization of novel oxoisoaporphine derivatives as dual inhibitors for cholinesterases and amyloid beta aggregation.
Li YP; Ning FX; Yang MB; Li YC; Nie MH; Ou TM; Tan JH; Huang SL; Li D; Gu LQ; Huang ZS
Eur J Med Chem; 2011 May; 46(5):1572-81. PubMed ID: 21367493
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of acetylcholinesterase, beta-amyloid aggregation, and NMDA receptors in Alzheimer's disease: a promising direction for the multi-target-directed ligands gold rush.
Rosini M; Simoni E; Bartolini M; Cavalli A; Ceccarini L; Pascu N; McClymont DW; Tarozzi A; Bolognesi ML; Minarini A; Tumiatti V; Andrisano V; Mellor IR; Melchiorre C
J Med Chem; 2008 Aug; 51(15):4381-4. PubMed ID: 18605718
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, biological evaluation of 9-N-substituted berberine derivatives as multi-functional agents of antioxidant, inhibitors of acetylcholinesterase, butyrylcholinesterase and amyloid-β aggregation.
Shan WJ; Huang L; Zhou Q; Meng FC; Li XS
Eur J Med Chem; 2011 Dec; 46(12):5885-93. PubMed ID: 22019228
[TBL] [Abstract][Full Text] [Related]
9. O-Hydroxyl- or o-amino benzylamine-tacrine hybrids: multifunctional biometals chelators, antioxidants, and inhibitors of cholinesterase activity and amyloid-β aggregation.
Mao F; Huang L; Luo Z; Liu A; Lu C; Xie Z; Li X
Bioorg Med Chem; 2012 Oct; 20(19):5884-92. PubMed ID: 22944335
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and evaluation of heterobivalent tacrine derivatives as potential multi-functional anti-Alzheimer agents.
Luo W; Li YP; He Y; Huang SL; Li D; Gu LQ; Huang ZS
Eur J Med Chem; 2011 Jun; 46(6):2609-16. PubMed ID: 21497959
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, biological evaluation, and molecular modeling of berberine derivatives as potent acetylcholinesterase inhibitors.
Huang L; Shi A; He F; Li X
Bioorg Med Chem; 2010 Feb; 18(3):1244-51. PubMed ID: 20056426
[TBL] [Abstract][Full Text] [Related]
12. Tacrine-melatonin hybrids as multifunctional agents for Alzheimer's disease, with cholinergic, antioxidant, and neuroprotective properties.
Fernández-Bachiller MI; Pérez C; Campillo NE; Páez JA; González-Muñoz GC; Usán P; García-Palomero E; López MG; Villarroya M; García AG; Martínez A; Rodríguez-Franco MI
ChemMedChem; 2009 May; 4(5):828-41. PubMed ID: 19308922
[TBL] [Abstract][Full Text] [Related]
13. Antioxidant and acetylcholinesterase inhibition properties of novel bromophenol derivatives.
Öztaşkın N; Çetinkaya Y; Taslimi P; Göksu S; Gülçin İ
Bioorg Chem; 2015 Jun; 60():49-57. PubMed ID: 25956827
[TBL] [Abstract][Full Text] [Related]
14. New potential AChE inhibitor candidates.
de Paula AA; Martins JB; dos Santos ML; Nascente Lde C; Romeiro LA; Areas TF; Vieira KS; Gambôa NF; Castro NG; Gargano R
Eur J Med Chem; 2009 Sep; 44(9):3754-9. PubMed ID: 19446931
[TBL] [Abstract][Full Text] [Related]
15. Site-activated chelators targeting acetylcholinesterase and monoamine oxidase for Alzheimer's therapy.
Zheng H; Youdim MB; Fridkin M
ACS Chem Biol; 2010 Jun; 5(6):603-10. PubMed ID: 20455574
[TBL] [Abstract][Full Text] [Related]
16. Structure-activity relationships of acetylcholinesterase noncovalent inhibitors based on a polyamine backbone. 4. Further investigation on the inner spacer.
Tumiatti V; Milelli A; Minarini A; Rosini M; Bolognesi ML; Micco M; Andrisano V; Bartolini M; Mancini F; Recanatini M; Cavalli A; Melchiorre C
J Med Chem; 2008 Nov; 51(22):7308-12. PubMed ID: 18954037
[TBL] [Abstract][Full Text] [Related]
17. Acetylcholinesterase inhibitors: synthesis and structure-activity relationships of omega-[N-methyl-N-(3-alkylcarbamoyloxyphenyl)- methyl]aminoalkoxyheteroaryl derivatives.
Rampa A; Bisi A; Valenti P; Recanatini M; Cavalli A; Andrisano V; Cavrini V; Fin L; Buriani A; Giusti P
J Med Chem; 1998 Oct; 41(21):3976-86. PubMed ID: 9767635
[TBL] [Abstract][Full Text] [Related]
18. Propidium-based polyamine ligands as potent inhibitors of acetylcholinesterase and acetylcholinesterase-induced amyloid-beta aggregation.
Bolognesi ML; Andrisano V; Bartolini M; Banzi R; Melchiorre C
J Med Chem; 2005 Jan; 48(1):24-7. PubMed ID: 15633997
[TBL] [Abstract][Full Text] [Related]
19. 2-Phenoxy-indan-1-one derivatives as acetylcholinesterase inhibitors: a study on the importance of modifications at the side chain on the activity.
Shen Y; Sheng R; Zhang J; He Q; Yang B; Hu Y
Bioorg Med Chem; 2008 Aug; 16(16):7646-53. PubMed ID: 18662884
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and pharmacological evaluation of hybrid molecules out of quinazolinimines and lipoic acid lead to highly potent and selective butyrylcholinesterase inhibitors with antioxidant properties.
Decker M; Kraus B; Heilmann J
Bioorg Med Chem; 2008 Apr; 16(8):4252-61. PubMed ID: 18343673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
